secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED THERAPEUTICS Corp (UTHR)
CIK:        0001082554
Form:       8-K
Filed at:   2024-06-27T23:59:59+00:00
Accession:  0001104659-24-075375
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United Therapeutics shareholders elect Jan Malcolm to board, approve stock plan amendment adding 1.32M shares
--------------------------------------------------------------------------------

- Jan Malcolm, former Minnesota Health Commissioner, elected to board; replaces Prof. Katherine Klein who did not stand for re-election.
- Shareholders approved amendment to 2015 Stock Incentive Plan: adds 1,320,000 shares, extends expiration to April 25, 2034.
- All 11 director nominees elected; advisory resolution on executive compensation passed with 94.8% of votes cast.
- Ratification of Ernst & Young as independent auditor for 2024 approved by shareholders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/0001104659-24-075375-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1082554/000110465924075375/tm2418313d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-075375

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer